Literature / Brochures

Prefilled Syringe Manufacturing

Work with a Global Leader in Syringe Fill/Finish

Released by Baxter BioPharma Solutions 06.30.18

The experience you want plus the volume you need: 385,000,000 syringes manufactured over the past 5 years

BioPharma Solutions’ processes and systems, including high-speed contract manufacturing and automated inspection systems, are tailored to meet your parenteral manufacturing needs.

More Literature / Brochures by Baxter BioPharma Solutions

Brochures

Capabilities Brochure - The Promise of Science Max

Maximize your molecule's full potential. Formulation challenges. Clinical supply hurdles. Limited manufacturing capability or capacity. Market fluctuations and demand surges. Lifecycle management. Risk mitigation. Patent expiry concerns.…
07.06.18
Brochures

Baxter Facility - Halle/Westfalen, Germany

Complex Sterile Manufacturing with More Than 60 Years of Oncology Experience…
07.03.18
Brochures

The Promise of Science: Baxter’s Lyophilization

Experience Makes the Difference Optimizing lyophilization cycle times and improving stability for complex injectables is a critical component of parenteral product development. With this understanding, BioPharma Solutions established the Lyophiliz…
07.01.18
Brochures

Awards

Baxter has been honored to be recognized globally with various awards and distinctions by the industry, as well as by sustainability, community support and environmental organizations. Download the attached for a sampling, with a full list available…
06.27.18
Brochures

Bloomington, Indiana, USA Facility Facts/Capabilit

A Global Leader in Sterile Contract Manufacturing
06.23.18
Brochures

Halle/Westfalen, Germany Facility Facts/Capabiliti

Complex Sterile Manufacturing with More Than 60 Years of Oncology Experience
01.30.17

More Content From Baxter BioPharma Solutions

Leak Rate Testing for Freeze Dryers: A Scientific Approach

Assurance of the vacuum integrity of freeze - dryers used for the manufacture of sterile pharmaceutical products is essential for GMP operations; however, there is currently no generally accepted scientific rationale for establishing acceptance crite…

White Papers / Tech Papers Released on 03.08.2019
Pharmaceutical Development for ADCs: Not as Simple as ABC

Formulation, process, and analytical development for antibody - drug conjugates, or ADCs, is complex. While the development of an aqueous solution formulation may be preferred over a lyophilized product, it is useful to initially pursue a dual path a…

White Papers / Tech Papers Released on 03.08.2019
Pharmaceutical Development for ADCs

Download the ADCs Poster.

Posters Released on 03.08.2019
Enhanced Delivery Options for Injectables

Download the Enhanced Delivery Options Poster.

Posters Released on 03.08.2019
BIOSIMILARS: Global Terminology, Strategy & Pathways

Download the Global Terminology, Strategy & Pathways Poster

Posters Released on 03.08.2019
Considerations for Development of Lyophilized Biosimilar

This whitepaper discusses considerations for development of a lyophilized biosimilar, as well as a biosimilar case study.

White Papers / Tech Papers Released on 11.01.2018
Your CMO for Sterile Injectables

85+ years of expertise in process and formulation development, technology transfer, and parenteral manufacturing.

Videos Released on 10.19.2018
Baxter's BioPharma Solutions Business Recognized with ViE Award for Fifth Time

Baxter’s BioPharma Solutions facility in Bloomington, Indiana, was recognized for the fifth time as Best Contract Manufacturing Organization at the annual Vaccine Industry Excellence (ViE) Awards, held during the 2017 World Vaccine Congress in…

News Releases Released on 07.06.2018
Manufacturing of Cytotoxic and Non-Cytotoxic Drugs in a Multiproduct Facility

When different drug products are produced in shared facilities, the potential for cross contamination is always a concern.

White Papers / Tech Papers Released on 07.06.2018
Process Development for Lyophilized Products

A common approach to process development for lyophilized products is to thermally characterize the solution formulation to determine the critical product temperature that should not be exceeded during primary drying. This is conducted using different…

White Papers / Tech Papers Released on 07.05.2018
Support of Scale-Up and Technical Transfer Through Understanding Equipment for Lyophilization

Formulation and process development for injectable products are typically conducted at laboratory-scale. Laboratory-scale equipment is useful and necessary during development when there is little technical information available and especially when th…

White Papers / Tech Papers Released on 07.03.2018
Best Practices in Formulation and Lyophilization Development: Proteins, mAbs and ADCs

The ultimate goal of formulation development is a stable product. In the case of a protein product, that can be defined as delivering the correct dose, in the native secondary and tertiary structure, without unintended chemical modifications, and fre…

White Papers / Tech Papers Released on 08.01.2016
Baxter BioPharma Solutions Wins the 2016 ISPE Facility of the Year Awards (FOYA)

In the Operational Excellence Category

News Releases Released on 02.22.2016
Baxter Completes Capacity Expansion at Halle, Germany Facility

Supports BioPharma Solutions’ Oncology Contract Manufacturing Services

News Releases Released on 11.12.2015
Supply Chain | Validation

Baxter BioPharma Solutions and SAFC Collaborate on Complete ADC Offering

Baxter ’s BioPharma Solutions business and SAFC have established a collaborative manufacturing agreement

News Releases Released on 09.01.2014